These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35701050)

  • 1. Persistence of gastrointestinal symptoms in irritable bowel syndrome and ulcerative colitis: study protocol for a three-arm randomised controlled trial (SOMA.GUT-RCT).
    Löwe B; Nestoriuc Y; Andresen V; Vettorazzi E; Zapf A; Hübener S; Maehder K; Peters L; Lohse AW
    BMJ Open; 2022 Jun; 12(6):e059529. PubMed ID: 35701050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
    Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
    Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of eye movement desensitization and reprocessing (EMDR) on abdominal pain in patients with irritable bowel syndrome (IBS): a study protocol for a randomized controlled trial (EMDR4IBS).
    Wertheim B; Aarts EE; de Roos C; van Rood YR
    Trials; 2023 Dec; 24(1):785. PubMed ID: 38049872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of acupuncture in refractory irritable bowel syndrome: study protocol for a randomised controlled trial.
    Zhao J; Chen M; Wang X; Ye K; Shi S; Li H; Wang J; Chen X; Ni J; Wei Q; Shi Y; Hu Y; Sun J; Li D; Liu S; Li Z; Zheng H; Yu SG
    BMJ Open; 2021 Sep; 11(9):e045655. PubMed ID: 34518248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychological risk factors for Long COVID and their modification: study protocol of a three-arm, randomised controlled trial (SOMA.COV).
    Engelmann P; Büchel C; Frommhold J; Klose HFE; Lohse AW; Maehder K; Nestoriuc Y; Scherer M; Suling A; Toussaint A; Weigel A; Zapf A; Löwe B
    BJPsych Open; 2023 Nov; 9(6):e207. PubMed ID: 37920139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis.
    Yu FY; Huang SG; Zhang HY; Ye H; Chi HG; Zou Y; Lv RX; Zheng XB
    World J Gastroenterol; 2016 Mar; 22(12):3451-9. PubMed ID: 27022227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Psychosocial Support for People with Ulcerative Colitis and Irritable Bowel Syndrome: A Feasibility Study on Need, Focus and Viability].
    Uhlenbusch N; Manthey C; Nestoriuc Y; Andresen V; Lohse AW; Löwe B
    Psychother Psychosom Med Psychol; 2022 Nov; 72(11):481-490. PubMed ID: 35584778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with longstanding ulcerative colitis in remission do not have more irritable bowel syndrome-like symptoms than controls.
    Lundgren D; Rutegård J; Eklöf V; Palmqvist R; Karling P
    BMC Gastroenterol; 2016 Nov; 16(1):139. PubMed ID: 27881072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acupuncture for irritable bowel syndrome: study protocol for a multicenter randomized controlled trial.
    Pei LX; Geng H; Chen H; Wu XL; Chen L; Zhou JL; Ju L; Lu G; Xu WL; Qin S; Guo J; Yang EM; Sun JH
    Trials; 2018 Oct; 19(1):529. PubMed ID: 30285891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The severity of inflammation at onset of ulcerative colitis is not associated with IBS-like symptoms during clinical remission.
    Jonefjäll B; Simrén M; Öhman L; Lasson A; Svedlund J; Strid H
    J Crohns Colitis; 2015 Sep; 9(9):776-83. PubMed ID: 26079726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of functional dyspepsia-like symptoms in ulcerative colitis patients in clinical remission and overlap with irritable bowel syndrome-like symptoms.
    Kotani S; Fukuba N; Kawashima K; Mishima Y; Sonoyama H; Okimoto E; Tada Y; Oka A; Tamagawa Y; Oshima N; Mishiro T; Tobita H; Shibagaki K; Moriyama I; Ishimura N; Kushiyama Y; Fujishiro H; Ishihara S
    Scand J Gastroenterol; 2020 May; 55(5):560-564. PubMed ID: 32412797
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of the effectiveness and safety of ethosuximide in the treatment of abdominal pain related to irritable bowel syndrome - IBSET: protocol of a randomised, parallel, controlled, double-blind and multicentre trial.
    Kerckhove N; Scanzi J; Pereira B; Ardid D; Dapoigny M
    BMJ Open; 2017 Jul; 7(7):e015380. PubMed ID: 28720615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in mucosal neuropeptides in patients with irritable bowel syndrome and ulcerative colitis in remission: a role in pain symptom generation?
    Keszthelyi D; Troost FJ; Jonkers DM; Helyes Z; Hamer HM; Ludidi S; Vanhoutvin S; Venema K; Dekker J; Szolcsányi J; Masclee AA
    Eur J Pain; 2013 Oct; 17(9):1299-306. PubMed ID: 23529955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of acupuncture based on acupoint combination theory for irritable bowel syndrome: a study protocol for a multicenter randomized controlled trial.
    Sun JW; Sun ML; Li D; Zhao J; Shi SH; Li HX; Liu HM; Gao JX; Hu Y; Zheng H; Wang X; Xue RD; Feng X; Yu SG; Li ZG
    Trials; 2021 Oct; 22(1):719. PubMed ID: 34666815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social inequalities in aggravating factors of somatic symptom persistence (SOMA.SOC): study protocol for a mixed-method observational study focusing on irritable bowel syndrome and fatigue.
    von dem Knesebeck O; Barbek R; Makowski AC
    BMJ Open; 2023 Apr; 13(4):e070635. PubMed ID: 37094902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial.
    Bai T; Zeng H; Long Y; Li X; Sun X; Lan Y; Gao L; Zhang L; Feng Z; Hou X
    Trials; 2020 Jun; 21(1):597. PubMed ID: 32605578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ulcerative colitis and irritable bowel syndrome: relationships with quality of life.
    Ansari R; Attari F; Razjouyan H; Etemadi A; Amjadi H; Merat S; Malekzadeh R
    Eur J Gastroenterol Hepatol; 2008 Jan; 20(1):46-50. PubMed ID: 18090990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EHealth: self-management in inflammatory bowel disease and in irritable bowel syndrome using novel constant-care web applications. EHealth by constant-care in IBD and IBS.
    Pedersen N
    Dan Med J; 2015 Dec; 62(12):B5168. PubMed ID: 26621403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abdominal pain in patients with inflammatory bowel disease: association with single-nucleotide polymorphisms prevalent in irritable bowel syndrome and clinical management.
    Ledergerber M; Lang BM; Heinrich H; Biedermann L; Begré S; Zeitz J; Krupka N; Rickenbacher A; Turina M; Greuter T; Schreiner P; Roth R; Siebenhüner A; Vavricka SR; Rogler G; Beerenwinkel N; Misselwitz B;
    BMC Gastroenterol; 2021 Feb; 21(1):53. PubMed ID: 33546600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Home-based guided hypnotherapy for children with functional abdominal pain and irritable bowel syndrome in primary care: study protocol for a randomised controlled trial.
    Ganzevoort IN; Fokkema T; Mol-Alma HJ; Heida A; Van der Veen AL; Vermeulen K; Benninga MA; Vlieger AM; Berger MY; Holtman GA
    BMJ Open; 2023 May; 13(5):e069653. PubMed ID: 37156587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.